Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03686345
Title Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia (AML FLT3)
Acronym AML FLT3
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Niguarda Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.